Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1997 Mar;90(3):448–454. doi: 10.1111/j.1365-2567.1997.00448.x

The beta 1 integrin, very late activation antigen-4 on human neutrophils can contribute to neutrophil migration through connective tissue fibroblast barriers.

J X Gao 1, A C Issekutz 1
PMCID: PMC1456599  PMID: 9155654

Abstract

Polymorphonuclear leucocyte (PMNL) accumulation in extravascular tissues and inflammatory exudates is dependent on their migration through blood vessel endothelium and then through connective tissue. Previously we utilized a barrier of human synovial and dermal fibroblasts (HSF or HDF) grown on microporous filters, as a model of PMNL migration through connective tissue. Those studies showed that beta 2 (CD18) and the beta 1 integrins, very late activation antigen-5 (VLA-5) and VLA-6, in part mediate this PMNL migration. Here we report that VLA-4, which can also be expressed at low levels on activated PMNL, is also involved in PMNL migration induced by C5a through fibroblast (HSF and HDF) barriers, because monoclonal antibody (mAb) to VLA-4 significantly inhibited (by 20-30%) PMNL migration. Blocking the function of CD18, VLA-5 or VLA-6 was not required for detection of the VLA-4-mediated migration. Combination treatment with mAb to VLA-4 and with mAb to VLA-5 or to VLA-6 further inhibited PMNL migration, irrespective of whether CD11/CD18 mechanisms were blocked with anti-CD18 mAb or not. Treatment of PMNL with a peptide based on the VLA-4-binding domain in the CS-1 fragment of fibronectin, but not a control peptide, inhibited PMNL migration to a comparable extent to treatment with mAb to VLA-4. A low level of VLA-4 was expressed on C5a-activated PMNL, detected by immunofluorescence flow cytometry. These results suggest that VLA-4 can be mobilized by human peripheral blood PMNL and can, in addition to VLA-5, VLA-6 and CD11/CD18 integrins, mediate PMNL migration through connective tissue. This is in marked contrast to PMNL transendothelial migration, where beta 1 integrins appear to play no significant role.

Full text

PDF
448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama S. K., Yamada S. S., Chen W. T., Yamada K. M. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol. 1989 Aug;109(2):863–875. doi: 10.1083/jcb.109.2.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arfors K. E., Lundberg C., Lindbom L., Lundberg K., Beatty P. G., Harlan J. M. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 1987 Jan;69(1):338–340. [PubMed] [Google Scholar]
  3. Argenbright L. W., Letts L. G., Rothlein R. Monoclonal antibodies to the leukocyte membrane CD18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J Leukoc Biol. 1991 Mar;49(3):253–257. doi: 10.1002/jlb.49.3.253. [DOI] [PubMed] [Google Scholar]
  4. Bohnsack J. F. CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6. Blood. 1992 Mar 15;79(6):1545–1552. [PubMed] [Google Scholar]
  5. Bohnsack J. F., Zhou X. N. Divalent cation substitution reveals CD18- and very late antigen-dependent pathways that mediate human neutrophil adherence to fibronectin. J Immunol. 1992 Aug 15;149(4):1340–1347. [PubMed] [Google Scholar]
  6. Brown E. J., Goodwin J. L. Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes. J Exp Med. 1988 Mar 1;167(3):777–793. doi: 10.1084/jem.167.3.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  8. Chuluyan H. E., Osborn L., Lobb R., Issekutz A. C. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. J Immunol. 1995 Sep 15;155(6):3135–3134. [PubMed] [Google Scholar]
  9. Davis G. E. The Mac-1 and p150,95 beta 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res. 1992 Jun;200(2):242–252. doi: 10.1016/0014-4827(92)90170-d. [DOI] [PubMed] [Google Scholar]
  10. Drake W. T., Lopes N. N., Fenton J. W., 2nd, Issekutz A. C. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. Lab Invest. 1992 Nov;67(5):617–627. [PubMed] [Google Scholar]
  11. Furie M. B., Tancinco M. C., Smith C. W. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood. 1991 Oct 15;78(8):2089–2097. [PubMed] [Google Scholar]
  12. Gao J. X., Issekutz A. C. Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms. Immunology. 1995 Jul;85(3):485–494. [PMC free article] [PubMed] [Google Scholar]
  13. Gao J. X., Wilkins J., Issekutz A. C. Migration of human polymorphonuclear leukocytes through a synovial fibroblast barrier is mediated by both beta 2 (CD11/CD18) integrins and the beta 1 (CD29) integrins VLA-5 and VLA-6. Cell Immunol. 1995 Jul;163(2):178–186. doi: 10.1006/cimm.1995.1114. [DOI] [PubMed] [Google Scholar]
  14. Hakkert B. C., Kuijpers T. W., Leeuwenberg J. F., van Mourik J. A., Roos D. Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood. 1991 Nov 15;78(10):2721–2726. [PubMed] [Google Scholar]
  15. Hemler M. E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365–400. doi: 10.1146/annurev.iy.08.040190.002053. [DOI] [PubMed] [Google Scholar]
  16. Hogg N., Landis R. C. Adhesion molecules in cell interactions. Curr Opin Immunol. 1993 Jun;5(3):383–390. doi: 10.1016/0952-7915(93)90057-y. [DOI] [PubMed] [Google Scholar]
  17. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  18. Issekutz A. C., Chuluyan H. E., Lopes N. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J Leukoc Biol. 1995 Apr;57(4):553–561. doi: 10.1002/jlb.57.4.553. [DOI] [PubMed] [Google Scholar]
  19. Issekutz A. C., Issekutz T. B. Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J Exp Med. 1995 Mar 1;181(3):1197–1203. doi: 10.1084/jem.181.3.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Issekutz T. B. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo. J Immunol. 1991 Dec 15;147(12):4178–4184. [PubMed] [Google Scholar]
  21. Issekutz T. B., Miyasaka M., Issekutz A. C. Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J Exp Med. 1996 May 1;183(5):2175–2184. doi: 10.1084/jem.183.5.2175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kennel S. J., Epler R. G., Lankford T. K., Foote L. J., Dickas V., Canamucio M., Cavalierie R., Cosimelli M., Venturo I., Falcioni R. Second generation monoclonal antibodies to the human integrin alpha 6 beta 4. Hybridoma. 1990 Jun;9(3):243–255. doi: 10.1089/hyb.1990.9.243. [DOI] [PubMed] [Google Scholar]
  23. Kerst J. M., Sanders J. B., Slaper-Cortenbach I. C., Doorakkers M. C., Hooibrink B., van Oers R. H., von dem Borne A. E., van der Schoot C. E. Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way. Blood. 1993 Jan 15;81(2):344–351. [PubMed] [Google Scholar]
  24. Kubes P., Niu X. F., Smith C. W., Kehrli M. E., Jr, Reinhardt P. H., Woodman R. C. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J. 1995 Aug;9(11):1103–1111. [PubMed] [Google Scholar]
  25. Lobb R. R., Hemler M. E. The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest. 1994 Nov;94(5):1722–1728. doi: 10.1172/JCI117519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lund-Johansen F., Terstappen L. W. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol. 1993 Jul;54(1):47–55. doi: 10.1002/jlb.54.1.47. [DOI] [PubMed] [Google Scholar]
  27. Lundgren-Akerlund E., Olofsson A. M., Berger E., Arfors K. E. CD11b/CD18-dependent polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migration. Scand J Immunol. 1993 May;37(5):569–574. doi: 10.1111/j.1365-3083.1993.tb02573.x. [DOI] [PubMed] [Google Scholar]
  28. Luscinskas F. W., Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 1994 Sep;8(12):929–938. doi: 10.1096/fasebj.8.12.7522194. [DOI] [PubMed] [Google Scholar]
  29. Makarem R., Newham P., Askari J. A., Green L. J., Clements J., Edwards M., Humphries M. J., Mould A. P. Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1. J Biol Chem. 1994 Feb 11;269(6):4005–4011. [PubMed] [Google Scholar]
  30. Marlor C. W., Webb D. L., Bombara M. P., Greve J. M., Blue M. L. Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. Am J Pathol. 1992 May;140(5):1055–1060. [PMC free article] [PubMed] [Google Scholar]
  31. Masumoto A., Hemler M. E. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem. 1993 Jan 5;268(1):228–234. [PubMed] [Google Scholar]
  32. Mauch C., Kreig T. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am. 1990 Feb;16(1):93–107. [PubMed] [Google Scholar]
  33. May M. J., Entwistle G., Humphries M. J., Ager A. VCAM-1 is a CS1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium. J Cell Sci. 1993 Sep;106(Pt 1):109–119. doi: 10.1242/jcs.106.1.109. [DOI] [PubMed] [Google Scholar]
  34. Meerschaert J., Furie M. B. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol. 1995 Apr 15;154(8):4099–4112. [PubMed] [Google Scholar]
  35. Monboisse J. C., Garnotel R., Randoux A., Dufer J., Borel J. P. Adhesion of human neutrophils to and activation by type-I collagen involving a beta 2 integrin. J Leukoc Biol. 1991 Oct;50(4):373–380. doi: 10.1002/jlb.50.4.373. [DOI] [PubMed] [Google Scholar]
  36. Morales-Ducret J., Wayner E., Elices M. J., Alvaro-Gracia J. M., Zvaifler N. J., Firestein G. S. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol. 1992 Aug 15;149(4):1424–1431. [PubMed] [Google Scholar]
  37. Morzycki W., Issekutz A. C. Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism. Immunology. 1991 Sep;74(1):107–113. [PMC free article] [PubMed] [Google Scholar]
  38. Osborn L., Vassallo C., Browning B. G., Tizard R., Haskard D. O., Benjamin C. D., Dougas I., Kirchhausen T. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol. 1994 Feb;124(4):601–608. doi: 10.1083/jcb.124.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pulido R., Elices M. J., Campanero M. R., Osborn L., Schiffer S., García-Pardo A., Lobb R., Hemler M. E., Sánchez-Madrid F. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes. J Biol Chem. 1991 Jun 5;266(16):10241–10245. [PubMed] [Google Scholar]
  40. Rieu P., Lesavre P., Halbwachs-Mecarelli L. Evidence for integrins other than beta 2 on polymorphonuclear neutrophils: expression of alpha 6 beta 1 heterodimer. J Leukoc Biol. 1993 May;53(5):576–582. doi: 10.1002/jlb.53.5.576. [DOI] [PubMed] [Google Scholar]
  41. Schwachula A., Riemann D., Kehlen A., Langner J. Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiology. 1994 Feb;190(1-2):67–92. doi: 10.1016/S0171-2985(11)80284-6. [DOI] [PubMed] [Google Scholar]
  42. Singer I. I., Scott S., Kawka D. W., Kazazis D. M. Adhesomes: specific granules containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes. J Cell Biol. 1989 Dec;109(6 Pt 1):3169–3182. doi: 10.1083/jcb.109.6.3169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Smith C. W., Marlin S. D., Rothlein R., Toman C., Anderson D. C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989 Jun;83(6):2008–2017. doi: 10.1172/JCI114111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28;76(2):301–314. doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  45. Springer T. A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827–872. doi: 10.1146/annurev.ph.57.030195.004143. [DOI] [PubMed] [Google Scholar]
  46. Stewart M., Thiel M., Hogg N. Leukocyte integrins. Curr Opin Cell Biol. 1995 Oct;7(5):690–696. doi: 10.1016/0955-0674(95)80111-1. [DOI] [PubMed] [Google Scholar]
  47. Vonderheide R. H., Tedder T. F., Springer T. A., Staunton D. E. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol. 1994 Apr;125(1):215–222. doi: 10.1083/jcb.125.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Walzog B., Schuppan D., Heimpel C., Hafezi-Moghadam A., Gaehtgens P., Ley K. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen. Exp Cell Res. 1995 May;218(1):28–38. doi: 10.1006/excr.1995.1127. [DOI] [PubMed] [Google Scholar]
  49. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES